Luminex submits joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA
The multi-analyte respiratory panel combines Flu A/B and respiratory syncytial virus (RSV) targets with the SARS-CoV-2 target
The multi-analyte respiratory panel combines Flu A/B and respiratory syncytial virus (RSV) targets with the SARS-CoV-2 target
Crosslinking mass spectrometry (XL-MS) can leverage the PhoX Crosslinker and TIMS/PASEF methods with the large-scale use of accurate collision cross sections
Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and Europe
Explore the new technologies and techniques that promise to provide confidence and reproducibility in results
In a guest editorial from H.E.L Group, explore how pressurized bioreactors and synthetic biology can mitigate the dangerous effects of climate change
We take a look at some of the latest methods and technologies disrupting drug discovery and how they’re reshaping the industry
Films are water-soluble and dissolve by almost 90% in 24 hours
The White FOx aims to bring maximum flexibility, control, and insight to diagnostic development, life science and (bio)pharmaceutical research
LG Chem selects second and third drug targets following rapid progress in first program
MOBILion joins with investigators at the University of Georgia’s Complex Carbohydrate Research Center
Leveraging antibody-based proteomics in protein quantitative trait loci mapping for disease research
Learn how the National Institute of Biology in Slovenia has pioneered the use of digital PCR to improve the detection of genetically modified organisms (GMOs) and quantification of viral vectors